|

KLF4 Epigenetic Modulation

RECRUITINGSponsored by Azienda USL Reggio Emilia - IRCCS
Actively Recruiting
SponsorAzienda USL Reggio Emilia - IRCCS
Started2026-10
Est. completion2027-07
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The study investigates the epigenetic regulation of KLF4 during the progression from colorectal polyps to adenomas and carcinomas. Quantitative KLF4 methylation will be assessed in colorectal tissue samples obtained during routine colonoscopy, together with KLF4 gene expression and its correlation with methylation status in matched tissue samples. The study will also evaluate quantitative and site-specific molecular approaches for the assessment of KLF4 methylation.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients undergoing routine colonoscopy
* \> 18 years of age
* Diagnosed by S.C. Anatomia Patologica, AUSL-IRCCS Reggio Emilia

Exclusion Criteria:

* Concomitant diagnosis of colorectal carcinoma

Conditions3

CancerEpigeneticKLF4 Methylation

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.